Search for Clinical Trial Results
Acinic Cell Carcinoma - 46 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Alisertib and Gemcitabine Hydrochloride in Treating Patients With Solid Tumors or Pancreatic Cancer Condition:
|
Recruiting |
Study Name: High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery Condition:
Interventions: |
Recruiting |
Study Name: Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery Condition:
|
Recruiting |
Study Name: ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed By Surgery Condition:
|
Withdrawn |
Study Name: Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung Condition:
|
Recruiting |
Study Name: Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies Condition:
|
Active, not recruiting |
Study Name: Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery Condition:
|
Terminated |
Study Name: Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer Condition:
Interventions: |
Active, not recruiting |
Study Name: Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors Condition:
|
Completed |
Study Name: Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers Condition:
Date: 2004-11-05 Interventions: |